FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1

MLA

Jiyan Wang, et al. “FTO Promotes Colorectal Cancer Progression and Chemotherapy Resistance via Demethylating G6PD/PARP1.” Clinical and Translational Medicine, vol. 12, no. 3, Feb. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....899274bdfc9742b0d78af24ae5a28447&authtype=sso&custid=ns315887.

APA

Jiyan Wang, Yaya Qiao, Mingming Sun, Huanran Sun, Fei Xie, Hongkai Chang, Yingzhi Wang, Jiaqi Song, Sizhen Lai, Chenxin Yang, Xichuan Li, Shuangping Liu, Xuanzhu Zhao, Kemin Ni, Kewei Meng, Shuai Zhang, Changliang Shan, & Chunze Zhang. (2022). FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1. Clinical and Translational Medicine, 12(3).

Chicago

Jiyan Wang, Yaya Qiao, Mingming Sun, Huanran Sun, Fei Xie, Hongkai Chang, Yingzhi Wang, et al. 2022. “FTO Promotes Colorectal Cancer Progression and Chemotherapy Resistance via Demethylating G6PD/PARP1.” Clinical and Translational Medicine 12 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....899274bdfc9742b0d78af24ae5a28447&authtype=sso&custid=ns315887.